Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases. | ||||||
Clinical stage treatment for Myotonic Dystrophy Type 1 | ||||||
DiogenX is a regenerative diabetes treatment founded in 2019 by Jean-Pascal Tranié, Benjamin Charles and Patrick Collombat. | ||||||
Agonistic monoclonal antibody molecules | ||||||
Thabor Therapeutics Develops innovative treatments for mucosal inflammatory diseases | ||||||
Tridek-One develops first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases | ||||||
Alderaan Biotechnology is a treg depleting CD25 antibody. |